Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimal dose of intravenous oxycodone for postoperative pain after laparoscopic colorectal surgery
KCT0003137Phase 3
Key facts
- Status
- Recruiting
- Start
- Apr 2016
- Countries
- 1
- Sponsor
- Mundipharma
- Modality
- Small Molecules
- Drugs
- oxycodone
- Conditions
- postoperative pain
01
Overview
Phase 3 trial of oxycodone in postoperative pain, sponsored by Mundipharma. Started Apr 2016; status: recruiting.
02
Who it enrols
Patients undergoing laparoscopic colorectal surgery who require postoperative intravenous oxycodone analgesia; otherwise generally healthy surgical candidates.
Beyond the preview
Go deeper on KCT0003137.
Full results, competitive context and analysis are in the Gosset platform.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003137.